Literature DB >> 20650258

Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro.

G Kempka1, H J Ahr, W Rüther, G Schlüter.   

Abstract

Achilles tendon rupture is known to occur after administration of various drugs to patients. It is also reported to occur after treatment with fluoroquinolone and glucocorticoids. To study potential cytotoxic effects of fluoroquinolones (ciprofloxacin, pefloxacin, sparfloxacin) and triamcinolonacetonide on tendons an in vitro model of cultivated tendon cells (human, dog, mini-pig, rat, marmoset) was established. The cells were characterized by their morphological appearance and by the synthesis of proteoglycans and collagen type I. The cytotoxicity of the tested drugs was determined by measurement of mitochondrial dehydrogenase activity (MTT assay) and other parameters (viability, proteoglycan content, proliferation). These investigations revealed the following: (1) no marked differences were found between various species after ciprofloxacin treatment, only rat tendon cells reacted slightly less sensitively at the highest concentration (100 mug/ml); (2) no age-dependent effects of ciprofloxacin and triamcinolonacetonide were found in cultivated human tendon cells from patients of different ages; (3) the simultaneous administration of fluoroquinolones and triamcinolonacetonide resulted in a significantly greater reduction of cell viability than when they were administered alone. This could indicate that the combined administration of fluoroquinolones and glucocorticoids can favour the occurrence of tendon rupture.

Entities:  

Year:  1996        PMID: 20650258     DOI: 10.1016/s0887-2333(96)00050-1

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  9 in total

1.  The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 2.  Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data.

Authors:  Irene Blanco; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen.

Authors:  M A Simonin; P Gegout-Pottie; A Minn; P Gillet; P Netter; B Terlain
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells.

Authors:  Catherine Baugé; Sylvain Leclercq; Thierry Conrozier; Karim Boumediene
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

5.  Toxic effects of levofloxacin on rat annulus fibrosus cells: an in-vitro study.

Authors:  Zhi-Long Bai; Qian Chen; Si-Dong Yang; Feng Zhang; Hai-Ying Wang; Da-Long Yang; Wen-Yuan Ding
Journal:  Med Sci Monit       Date:  2014-11-08

6.  17β-Estradiol Inhibites Tumor Necrosis Factor-α Induced Apoptosis of Human Nucleus Pulposus Cells via the PI3K/Akt Pathway.

Authors:  Tao Wang; Si-Dong Yang; Sen Liu; Hui Wang; Huan Liu; Wen Yuan Ding
Journal:  Med Sci Monit       Date:  2016-11-12

7.  The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids.

Authors:  Christoph Spang; Jialin Chen; Ludvig J Backman
Journal:  BMC Musculoskelet Disord       Date:  2016-11-10       Impact factor: 2.362

8.  Effects of Redox Modulation on Cell Proliferation, Viability, and Migration in Cultured Rat and Human Tendon Progenitor Cells.

Authors:  Yuk Wa Lee; Sai Chuen Fu; Man Yi Yeung; Chun Man Lawrence Lau; Kai Ming Chan; Leung Kim Hung
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

9.  Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro.

Authors:  Erman Popowski; Benjamin Kohl; Tobias Schneider; Joachim Jankowski; Gundula Schulze-Tanzil
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.